Linked Life Data

17129361

Source:http://linkedlifedata.com/resource/pubmed/id/17129361

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17129361rdf:typepubmed:Citationlld:pubmed
pubmed-article:17129361lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0153690lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C2699153lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1269955lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1171350lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:17129361lifeskim:mentionsumls-concept:C1956526lld:lifeskim
pubmed-article:17129361pubmed:issue1lld:pubmed
pubmed-article:17129361pubmed:dateCreated2007-4-10lld:pubmed
pubmed-article:17129361pubmed:abstractTextTransforming growth factor (TGF)-beta signaling has been shown to promote tumor growth and metastasis in advanced cancer. Use of inhibitors of TGF-beta signaling may thus be a novel strategy for treatment of patients with such cancers. In this study, we investigated the effects of a novel TGF-beta type I receptor (TbetaR-I) kinase inhibitor, Ki26894, on bone metastasis of a highly bone-metastatic variant of human breast cancer MDA-MB-231 cells, termed MDA-MB-231-5a-D (MDA-231-D). Ki26894 blocked TGF-beta signaling in MDA-231-D cells, as detected by suppression of phosphorylation of Smad2 and inhibition of TGF-beta-responsive reporter activity. Moreover, Ki26894 decreased the motility and the invasion of MDA-231-D cells induced by TGF-beta in vitro. Ki26894 also suppressed transcription of plasminogen activator inhibitor-1 (PAI-1), parathyroid hormone-related protein (PTHrP), and interleukin-11 (IL-11) mRNA of MDA-231-D cells, which were stimulated by TGF-beta. X-ray radiography revealed that systemic Ki26894 treatment initiated 1 day before the inoculation of MDA-231-D cells into the left ventricle of BALB/cnu/nu female mice resulted in decreased bone metastasis of breast cancer cells. Moreover, Ki26894 prolonged the survival of mice inoculated with MDA-231-D cells compared to vehicle-treated mice. These findings suggest that TbetaR-I kinase inhibitors such as Ki26894 may be useful for blocking the progression of advanced cancers.lld:pubmed
pubmed-article:17129361pubmed:languageenglld:pubmed
pubmed-article:17129361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:citationSubsetIMlld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17129361pubmed:statusMEDLINElld:pubmed
pubmed-article:17129361pubmed:monthJanlld:pubmed
pubmed-article:17129361pubmed:issn1347-9032lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:MiyazonoKohei...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:ShimizuToshiy...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:ShimizuKiyosh...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:FujimeMakotoMlld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:ImamuraTakesh...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:OgataEtsuroElld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:IshikawaYuich...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:NomuraKimieKlld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:GotoKouichiro...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:HanyuAkiAlld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:EhataShogoSlld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:KatsunoYokoYlld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:FukunagaErina...lld:pubmed
pubmed-article:17129361pubmed:authorpubmed-author:YokooHiroshiHlld:pubmed
pubmed-article:17129361pubmed:issnTypePrintlld:pubmed
pubmed-article:17129361pubmed:volume98lld:pubmed
pubmed-article:17129361pubmed:ownerNLMlld:pubmed
pubmed-article:17129361pubmed:authorsCompleteYlld:pubmed
pubmed-article:17129361pubmed:pagination127-33lld:pubmed
pubmed-article:17129361pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:meshHeadingpubmed-meshheading:17129361...lld:pubmed
pubmed-article:17129361pubmed:year2007lld:pubmed
pubmed-article:17129361pubmed:articleTitleKi26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.lld:pubmed
pubmed-article:17129361pubmed:affiliationDepartment of Biochemistry, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.lld:pubmed
pubmed-article:17129361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17129361pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:17129361pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17129361lld:pubmed